This session on influenza diagnosis and management will improve how you respond when annual fluctuations in vaccine efficacy expose your patients to risk of serious illness. Through interactive patient cases, the faculty will demonstrate how to identify and treat patients with suspected influenza, including patients at high risk for complications. These practical, evidence-based strategies will help you to use antiviral medications effectively and reduce the burden of influenza.

Join us as we discuss the risks of elevated cholesterol when consuming coconut oil.

For patients who have hip replacement or knee arthroplasty there is an increased risk of venous thromboembolism (VTE). This episode will review the effectiveness of aspirin for preventing VTE in this population.

The available evidence on alcohol consumption and its relationship to health is abundant, varied, and often conflicting. The evidence that excessive consumption is associated with poor outcomes is consistent; however, evidence on low-to-moderate alcohol consumption has ranged from poor outcomes to no impact to improved outcomes. Join us while we discuss new evidence that reveals an association between low-to-moderate alcohol use in white middle-to-older aged adults and improved cognition.

Data are limited regarding statin therapy for primary prevention of atherosclerotic cardiovascular disease in adults 75 years and older. During this episode we will review recent studies on the use of statins in elderly patients and discuss how to consider this data in your clinical practice.

Currently a low-dose CT scan is the only screening test for lung cancer that is recommended by the American Cancer Society. In July 2020, the U.S. Preventive Services Task Force (USPSTF) issued a draft recommendation statement on screening for lung cancer. The USPSTF suggests annual screening with low-dose CT for individuals aged 50-80 who have a 20 pack-year smoking history and who currently smoke or have quit smoking within the past 15 years. These recommendations expand screening eligibility, but they also suggest that screening be discontinued if a person has not smoked for 15 years, develops a health problem that substantially limits life expectancy, or is unable or unwilling to have curative lung surgery.

There are many aspects of the COVID-19 pandemic that clinicians need to stay current with. In this episode we will briefly review ten hot topics related to COVID-19, including but not limited to: testing, vaccines, and reinfection.

This session will overview the new 2021 changes for outpatient E&M billing documentation requirements.

Various organizations develop guidelines to assist with patient care. This episode will review the most significant changes to the U.S. Department of Veterans Affairs and U.S. Department of Defense (VA/DoD) Clinical Practice Guidelines for the Management of Dyslipidemia for Cardiovascular Disease Risk Reduction.

Join us for the 200th episode of Frankly Speaking about Family Medicine! In this episode, each podcaster will review their favorite topics since the inception of this podcast and will describe patient encounters where this practice changing knowledge was helpful. .

Screening for asymptomatic conditions is an essential and important aspect of primary care. But what is the potential downstream impact to the patents and the healthcare system when low-risk individuals are screened? What are the benefits and the potential harms? Join us as we discuss a recent retrospective study on the downstream effects of low-value testing on low-risk people at their annual health exam and how this may impact your practice.

Microhematuria is a common finding. It is usually benign, but it needs proper evaluation since it may also be a sign of malignancy. A risk-based approach can avoid unnecessary testing, while still identifying those patients with malignancy. Recent American Urological Association (AUA) guidelines use a validated risk-based approach.